VGO-Cs01p
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VGO-Cs01p, covering 2025-05-15 to 2025-05-15. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia [EARLY_Phase 1]